- Home
- RRX vs BAX Comparison
RRX vs BAX Comparison
Compare RRX & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RRX | BAX |
|---|---|---|
| Founded | 1955 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.1B | 13.9B |
| IPO Year | 1994 | 1994 |
Fundamental Metrics
Financial Performance| Metric | RRX | BAX |
|---|---|---|
| Price | $174.18 | $26.02 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 10 | 9 |
| Target Price | ★ $210.70 | $21.00 |
| AVG Volume (30 Days) | 1.3M | ★ 7.6M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | ★ 0.69% | 0.24% |
| EPS Growth | ★ 42.86 | N/A |
| EPS | ★ 2.71 | 0.21 |
| Revenue | $3,257,100,000.00 | ★ $11,244,000,000.00 |
| Revenue This Year | $4.20 | $1.96 |
| Revenue Next Year | $12.13 | $2.22 |
| P/E Ratio | ★ $64.76 | $127.29 |
| Revenue Growth | 5.21 | ★ 5.72 |
| 52 Week Low | $127.96 | $15.73 |
| 52 Week High | $247.80 | $30.00 |
Technical Indicators
Market Signals| Indicator | RRX | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 36.17 | 56.68 |
| Support Level | $135.23 | $18.58 |
| Resistance Level | $221.59 | $30.00 |
| Average True Range (ATR) | 8.94 | 1.12 |
| MACD | -2.19 | -0.17 |
| Stochastic Oscillator | 7.83 | 33.65 |
Price Performance
Historical ComparisonAbout RRX Regal Rexnord Corporation
Regal Rexnord Corp is in the engineering and manufacturing of industrial powertrain solutions, power transmission components, electric motors, electronic controls, air-moving products, and specialty electrical components and systems, serving customers around the world. The three operating segments include Automation & Motion Control (AMC) segment; Industrial Powertrain Solutions (IPS) segment, which derives maximum revenue; and Power Efficiency Solutions (PES) segment. Geographically, the company operates in North America, Europe, Asia, and Rest of the world, of which it derives maximum revenue from North America.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.